CD34 and ovarian cancer: In addition, we used real-time quantitative reverse transcription polymerase chain reaction (RT-PCR) to evaluate mRNA levels of EPC-specific markers CD34 and vascular endothelial growth factor receptor 2 (VEGFR2) in the peripheral blood of ovarian cancer patients.